AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 277: H1808-H1816, 1999;
0363-6135/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, L.
Right arrow Articles by Ritchie, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, L.
Right arrow Articles by Ritchie, M. E.
Vol. 277, Issue 5, H1808-H1816, November 1999

Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo

L. Kim1, T. Lee1, J. Fu1, and M. E. Ritchie1,2,3

1 Division of Cardiology and Cardiovascular Research Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0542; 2 Division of Cardiology, Veterans Affairs Medical Center, Cincinnati, Ohio 45222; and 3 Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana 46202

Protein kinase C (PKC) and mitogen-activated protein (MAP) kinase activation appear important in conferring hypertrophy in vitro. However, the response of PKC and MAP kinase to stimuli known to induce hypertrophy in vivo has not been determined. We recently demonstrated that pressure-overload hypertrophy induced a transiently transfected gene driven by an hypertrophy responsive enhancer (HRE) through a marked increase in binding activity of its interacting nuclear factor (HRF). These data suggested that the HRE/HRF could serve as a target for evaluating the signal transduction events responsible for hypertrophy in vivo. Accordingly, we characterized MAP kinase and PKC isoform activation, injected HRE driven reporter gene expression, and HRF binding activity in rat hearts subjected to ascending aortic clipping or sham operation in the presence of the angiotensin-converting enzyme (ACE) inhibitor fosinopril, hydralazine, or no treatment. Analyses showed that PKC-epsilon and MAP kinase were acutely activated following ascending aortic ligature and that fosinopril significantly inhibited but did not completely abrogate PKC-epsilon and MAP kinase activation. However, fosinopril completely prevented pressure overload-mediated induction of HRE containing constructs and obviated increased HRF binding activity. These results suggest a direct relationship between ACE activity and HRE/HRF-mediated gene activation and imply that PKC-epsilon and MAP kinase may be involved in transducing this signal.

angiotensin-converting enzyme; protein kinase C; mitogen-activated protein kinase; BCK promoter; gene activation; hypertrophy; nuclear factors


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Malhotra, R. Begley, B. P. S. Kang, I. Rana, J. Liu, G. Yang, D. Mochly-Rosen, and L. G. Meggs
PKC-{varepsilon}-dependent survival signals in diabetic hearts
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1343 - H1350.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. M. Littler, K. G. Morris Jr., K. A. Fagan, I. F. McMurtry, R. O. Messing, and E. C. Dempsey
Protein kinase C-epsilon -null mice have decreased hypoxic pulmonary vasoconstriction
Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1321 - H1331.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. W. Carter and N. L. Kanagy
Mechanism of enhanced calcium sensitivity and alpha 2-AR vasoreactivity in chronic NOS inhibition hypertension
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H309 - H316.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. G. Pyle, M. P. Sumandea, R. J. Solaro, and P. P. De Tombe
Troponin I serines 43/45 and regulation of cardiac myofilament function
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1215 - H1224.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Bayer, M. C. Heidkamp, N. Patel, M. J. Porter, S. J. Engman, and A. M. Samarel
PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H695 - H706.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Pass, Y. Zheng, W. B. Wead, J. Zhang, R. C. X. Li, R. Bolli, and P. Ping
PKC{epsilon} activation induces dichotomous cardiac phenotypes and modulates PKC{epsilon}-RACK interactions and RACK expression
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H946 - H955.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. B. Strait III, J. L. Martin, A. Bayer, R. Mestril, D. M. Eble, and A. M. Samarel
Role of protein kinase C-{epsilon} in hypertrophy of cultured neonatal rat ventricular myocytes
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H756 - H766.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online